Kobari Y, Nakajima N, Saito A, Katsurayama N, et al. Effectiveness and Safety of Enfortumab Vedotin Plus Pembrolizumab for Patients Aged 80 Years and Older With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study. Anticancer Res 2026;46:4453-4460.
PMID: 42527056